Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme

OBJECTIVES: To evaluate the extent to which patients with type 2 diabetes discontinue metformin therapy when initiating second-line treatment and factors associated with metformin discontinuation, using baseline data from the DISCOVER study programme. DESIGN: DISCOVER is a 3-year, prospective, obser...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Autores principales: Khunti, Kamlesh, Gomes, Marilia B, Kosiborod, Mikhail, Nicolucci, Antonio, Pocock, Stuart, Rathmann, Wolfgang, Shestakova, Marina V, Shimomura, Iichiro, Watada, Hirotaka, Chen, Hungta, Cid-Ruzafa, Javier, Fenici, Peter, Hammar, Niklas, Tang, Fengming, Ji, Linong
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Diabetes and Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462233/
https://ncbi.nlm.nih.gov/pubmed/32868349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034613
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares